AI Prospecting for AbbVie
Company data:
Company size:
50000 employeesWebsite URL:
https://www.abbvie.comIndustry
BiopharmaceuticalHeadquarters:
North Chicago, Illinois, USAInvestment round:
NYSE: ABBVARR:
$56 billionKey stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about AbbVie
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
AbbVie announced the European Commission's approval of RINVOQ® (upadacitinib) for treating adults with giant cell arteritis, as of April 8, 2025. Additionally, AbbVie is showcasing early oncology research, including data on ABBV-969 and ABBV-514, at the AACR Annual Meeting 2025[1][4].
AbbVie will announce its first-quarter 2025 financial results on April 25, 2025, before the market opens. The company will also pay out a dividend of $1.64 per share, with the ex-date, record date, and payment date set for April 15, 2025, and May 15, 2025, respectively[4][5].
AbbVie will host a live webcast of its first-quarter 2025 earnings conference call on April 25, 2025, at 8 a.m. Central time, accessible through AbbVie’s Investor Relations website, with an archived edition available later that day[5].
Open job positions at AbbVie
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Specialist, Promotion Material
Statistical Programmer (Immunology)
Associate Director, Consumer Marketing - Psychiatry
